Dyne Therapeutics Inc
DYNHealthcare|Biotechnology|USA
$23.43
-0.84 (-3.48%)
Tangible Book
$5.24
Earnings Power
$4.45
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (187)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Rhodes Jason P | Director | 2026-07-07 | SELL | 777,451 | $22.97 | $17858K |
| Rhodes Jason P | Director | 2026-06-29 | SELL | 504,695 | $21.23 | $10714.7K |
| Rhodes Jason P | Director | 2026-06-25 | SELL | 267,760 | $21.09 | $5647.1K |
| Lucera Erick | CFO | 2026-06-25 | SELL | 2,362 | $20.37 | $48.1K |
| Kersten Dirk | Director | 2026-06-23 | SELL | 263,962 | $20.7 | $5464K |
| Kersten Dirk | Director | 2026-06-18 | SELL | 84,355 | $20.1 | $1695.5K |
| Kerr Douglas | Chief Medical Officer | 2026-06-16 | SELL | 887 | $18.33 | $16.3K |
| Friedl-Naderer Johanna | Chief Commercial Officer | 2026-06-16 | SELL | 145 | $18.33 | $2.7K |
| Cox John | CEO & President | 2026-06-16 | SELL | 2,683 | $18.33 | $49.2K |
| Posner Brian S | Director | 2026-06-08 | BUY | 2,000 | $16.94 | $33.9K |
| Posner Brian S | Director | 2026-06-03 | BUY | 2,500 | $17.48 | $43.7K |
| Posner Brian S | Director | 2026-05-26 | BUY | 2,000 | $18.21 | $36.4K |
| Posner Brian S | Director | 2026-05-20 | BUY | 2,500 | $17.12 | $42.8K |
| Lucera Erick | CFO | 2026-05-13 | SELL | 1,448 | $18.36 | $26.6K |
| Kerr Douglas | Chief Medical Officer | 2026-05-13 | SELL | 1,564 | $18.36 | $28.7K |
| Cox John | CEO & President | 2026-05-13 | SELL | 3,311 | $18.36 | $60.8K |
| Friedl-Naderer Johanna | Chief Commercial Officer | 2026-05-13 | SELL | 228 | $18.36 | $4.2K |
| Rhodes Jason P | Director | 2026-05-06 | SELL | 106,723 | $18.14 | $1936K |
| Rhodes Jason P | Director | 2026-04-28 | SELL | 227,337 | $18.38 | $4178.5K |
| Rhodes Jason P | Director | 2026-04-27 | SELL | 384,549 | $18.47 | $7102.6K |
| Rhodes Jason P | Director | 2026-04-22 | SELL | 834,302 | $19.75 | $16477.5K |
| Kersten Dirk | Director | 2026-04-22 | SELL | 10,952 | $20.01 | $219.1K |
| Kersten Dirk | Director | 2026-04-20 | SELL | 337,248 | $20.21 | $6815.8K |
| Kersten Dirk | Director | 2026-04-16 | SELL | 99,613 | $20.35 | $2027.1K |
| Lucera Erick | CFO | 2026-04-01 | SELL | 5,727 | $18.64 | $106.8K |
| Posner Brian S | Director | 2026-03-30 | BUY | 2,000 | $17.08 | $34.2K |
| Kersten Dirk | Director | 2026-03-11 | SELL | 129,672 | $19.52 | $2531.2K |
| Posner Brian S | Director | 2026-03-11 | BUY | 2,000 | $19.35 | $38.7K |
| Kersten Dirk | Director | 2026-03-10 | SELL | 688,788 | $19.09 | $13149K |
| Posner Brian S | Director | 2026-03-06 | BUY | 3,000 | $15.06 | $45.2K |
| Friedl-Naderer Johanna | Chief Commercial Officer | 2026-03-05 | SELL | 148 | $14.9 | $2.2K |
| Kerr Douglas | Chief Medical Officer | 2026-03-05 | SELL | 904 | $14.9 | $13.5K |
| Cox John | CEO & President | 2026-03-05 | SELL | 2,732 | $14.9 | $40.7K |
| Cox John | CEO & President | 2025-12-05 | SELL | 2,662 | $20.72 | $55.2K |
| Kerr Douglas | Chief Medical Officer | 2025-12-05 | SELL | 880 | $20.72 | $18.2K |
| Friedl-Naderer Johanna | Chief Commercial Officer | 2025-12-05 | SELL | 144 | $20.72 | $3K |
| Cox John | CEO & President | 2025-09-05 | SELL | 2,640 | $13.41 | $35.4K |
| Friedl-Naderer Johanna | Chief Commercial Officer | 2025-09-05 | SELL | 1,038 | $13.29 | $13.8K |
| Kerr Douglas | Chief Medical Officer | 2025-09-05 | SELL | 4,425 | $13.3 | $58.9K |
| Cox John | CEO & President | 2025-07-14 | BUY | 100,000 | $9.11 | $911K |
| Cox John | CEO & President | 2025-06-05 | SELL | 4,060 | $13.35 | $54.2K |
| Kerr Douglas | Chief Medical Officer | 2025-06-05 | SELL | 1,342 | $13.35 | $17.9K |
| Friedl-Naderer Johanna | Chief Commercial Officer | 2025-06-05 | SELL | 146 | $13.35 | $1.9K |
| Friedl-Naderer Johanna | Chief Commercial Officer | 2025-03-13 | SELL | 143 | $12.12 | $1.7K |
| Scalzo Richard William | SVP, Head of Finance & Admin. | 2025-03-11 | SELL | 1,343 | $11.38 | $15.3K |
| Beskrovnaya Oxana | Chief Scientific Officer | 2025-03-11 | SELL | 2,153 | $11.38 | $24.5K |
| Cox John | CEO & President | 2025-03-05 | SELL | 4,061 | $11.83 | $48K |
| Beskrovnaya Oxana | Chief Scientific Officer | 2025-02-18 | SELL | 2,598 | $13.95 | $36.2K |
| Scalzo Richard William | SVP, Head of Finance & Admin. | 2025-02-18 | SELL | 2,488 | $13.95 | $34.7K |
| Beskrovnaya Oxana | Chief Scientific Officer | 2024-12-11 | SELL | 2,334 | $28.12 | $65.6K |
| Scalzo Richard William | SVP, Head of Finance & Admin. | 2024-12-11 | SELL | 1,455 | $28.12 | $40.9K |
| Kersten Dirk | Director | 2024-12-09 | SELL | 136,112 | $29.3 | $3988.1K |
| Kersten Dirk | Director | 2024-12-05 | SELL | 138,845 | $29.38 | $4079.3K |
| Kersten Dirk | Director | 2024-12-03 | SELL | 110,933 | $29.5 | $3272.5K |
| Incerti Carlo | Director | 2024-11-18 | SELL | 16,500 | $28.73 | $474K |
| Scalzo Richard William | SVP, Head of Finance & Admin. | 2024-11-18 | SELL | 2,735 | $28.2 | $77.1K |
| Beskrovnaya Oxana | Chief Scientific Officer | 2024-11-18 | SELL | 2,856 | $28.2 | $80.5K |
| Rhodes Jason P | Director | 2024-11-14 | SELL | 782 | $33.1 | $25.9K |
| Kersten Dirk | Director | 2024-11-14 | SELL | 19,732 | $34.14 | $673.7K |
| Kersten Dirk | Director | 2024-10-21 | SELL | 13,535 | $35.16 | $475.9K |
| Kersten Dirk | Director | 2024-10-17 | SELL | 36,684 | $35.29 | $1294.6K |
| Kersten Dirk | Director | 2024-10-03 | SELL | 5,441 | $35.13 | $191.1K |
| Kersten Dirk | Director | 2024-10-02 | SELL | 29,941 | $35.32 | $1057.5K |
| Kersten Dirk | Director | 2024-09-30 | SELL | 30,974 | $35.5 | $1099.6K |
| Kersten Dirk | Director | 2024-09-26 | SELL | 3,617 | $35.14 | $127.1K |
| Kersten Dirk | Director | 2024-09-23 | SELL | 120,242 | $36.07 | $4337.1K |
| Kersten Dirk | Director | 2024-09-19 | SELL | 80,293 | $36.15 | $2902.6K |
| HIGH SUSANNA GATTI | COO | 2024-09-18 | SELL | 8,976 | $34.41 | $308.9K |
| Scalzo Richard William | SVP, Head of Finance & Admin. | 2024-09-18 | SELL | 1,390 | $34.55 | $48K |
| Beskrovnaya Oxana | Chief Scientific Officer | 2024-09-18 | SELL | 2,339 | $34.55 | $80.8K |
| Kersten Dirk | Director | 2024-09-17 | SELL | 4,592 | $35.1 | $161.2K |
| Beskrovnaya Oxana | Chief Scientific Officer | 2024-09-11 | SELL | 2,161 | $31.89 | $68.9K |
| Scalzo Richard William | SVP, Head of Finance & Admin. | 2024-09-11 | SELL | 1,468 | $31.89 | $46.8K |
| HIGH SUSANNA GATTI | COO | 2024-09-11 | SELL | 5,270 | $31.89 | $168.1K |
| Scalzo Richard William | SVP, Head of Finance & Admin. | 2024-09-06 | SELL | 126,074 | $32.15 | $4053.3K |
| Kersten Dirk | Director | 2024-09-05 | SELL | 1,577 | $35.03 | $55.2K |
| Cox John | CEO & President | 2024-09-04 | BUY | 32,000 | $33.04 | $1057.3K |
| Kersten Dirk | Director | 2024-08-30 | SELL | 31,300 | $45.59 | $1427K |
| Kersten Dirk | Director | 2024-08-29 | SELL | 134,261 | $45.03 | $6045.8K |
| Kersten Dirk | Director | 2024-08-27 | SELL | 154,900 | $44.87 | $6950.4K |
| Kersten Dirk | Director | 2024-08-23 | SELL | 180,409 | $46.02 | $8302.4K |
| Kersten Dirk | Director | 2024-08-21 | SELL | 222,603 | $46.61 | $10375.5K |
| Kersten Dirk | Director | 2024-08-19 | SELL | 248,675 | $45.48 | $11309.7K |
| Scalzo Richard William | SVP, Head of Finance & Admin. | 2024-08-19 | SELL | 2,752 | $45.12 | $124.2K |
| McNeill Jonathan | Chief Business Officer | 2024-08-19 | SELL | 2,705 | $45.12 | $122K |
| Farwell Wildon | Chief Medical Officer | 2024-08-19 | SELL | 2,321 | $45.12 | $104.7K |
| HIGH SUSANNA GATTI | COO | 2024-08-19 | SELL | 2,910 | $45.12 | $131.3K |
| Beskrovnaya Oxana | Chief Scientific Officer | 2024-08-19 | SELL | 2,636 | $45.12 | $118.9K |
| Kersten Dirk | Director | 2024-08-15 | SELL | 281,541 | $44.76 | $12601.8K |
| Kersten Dirk | Director | 2024-08-13 | SELL | 212,477 | $42.93 | $9121.6K |
| Kersten Dirk | Director | 2024-08-09 | SELL | 183,834 | $42.85 | $7877.3K |
| Kersten Dirk | Director | 2024-08-09 | SELL | 183,834 | $42.85 | $7877.3K |
| HIGH SUSANNA GATTI | COO | 2024-06-24 | SELL | 40,000 | $35.09 | $1403.6K |
| HIGH SUSANNA GATTI | COO | 2024-06-24 | SELL | 39,950 | $35.09 | $1401.8K |
| HIGH SUSANNA GATTI | COO | 2024-06-12 | SELL | 40,000 | $33.36 | $1334.4K |
| Beskrovnaya Oxana | Chief Scientific Officer | 2024-06-11 | SELL | 2,136 | $31.34 | $66.9K |
| Farwell Wildon | Chief Medical Officer | 2024-06-11 | SELL | 2,636 | $31.27 | $82.4K |
| HIGH SUSANNA GATTI | COO | 2024-06-11 | SELL | 85,270 | $30.3 | $2583.7K |
| McNeill Jonathan | Chief Business Officer | 2024-06-11 | SELL | 1,823 | $31.34 | $57.1K |
| Scalzo Richard William | SVP, Head of Finance & Admin. | 2024-06-11 | SELL | 2,921 | $30.74 | $89.8K |
| Beskrovnaya Oxana | Chief Scientific Officer | 2024-05-20 | SELL | 30,426 | $32.96 | $1002.8K |
| Beskrovnaya Oxana | Chief Scientific Officer | 2024-05-16 | SELL | 2,705 | $28.27 | $76.5K |
| Farwell Wildon | Chief Medical Officer | 2024-05-16 | SELL | 2,381 | $28.27 | $67.3K |
| HIGH SUSANNA GATTI | COO | 2024-05-16 | SELL | 2,738 | $28.27 | $77.4K |
| Scalzo Richard William | SVP, Head of Finance & Admin. | 2024-05-16 | SELL | 2,588 | $28.27 | $73.2K |
| McNeill Jonathan | Chief Business Officer | 2024-05-16 | SELL | 2,774 | $28.27 | $78.4K |
| Farwell Wildon | Chief Medical Officer | 2024-03-12 | SELL | 2,615 | $25.65 | $67.1K |
| Scalzo Richard William | SVP, Head of Finance & Admin. | 2024-03-11 | SELL | 88,924 | $26.19 | $2328.9K |
| Brumm Joshua T | CEO & President | 2024-03-11 | SELL | 429,730 | $25.89 | $11125.7K |
| Beskrovnaya Oxana | Chief Scientific Officer | 2024-03-11 | SELL | 2,081 | $25.7 | $53.5K |
| HIGH SUSANNA GATTI | COO | 2024-03-11 | SELL | 29,491 | $26.59 | $784.2K |
| McNeill Jonathan | Chief Business Officer | 2024-03-11 | SELL | 109,601 | $26.11 | $2861.7K |
| Brumm Joshua T | CEO & President | 2024-03-07 | SELL | 9,086 | $25.85 | $234.9K |
| Beskrovnaya Oxana | Chief Scientific Officer | 2024-03-07 | SELL | 2,373 | $25.85 | $61.3K |
| HIGH SUSANNA GATTI | COO | 2024-03-07 | SELL | 1,591 | $25.85 | $41.1K |
| Farwell Wildon | Chief Medical Officer | 2024-03-07 | SELL | 9,921 | $25.86 | $256.6K |
| McNeill Jonathan | Chief Business Officer | 2024-03-07 | SELL | 2,434 | $25.85 | $62.9K |
| Scalzo Richard William | SVP, Head of Finance & Admin. | 2024-03-07 | SELL | 2,273 | $25.85 | $58.8K |
| Brumm Joshua T | CEO & President | 2024-03-01 | SELL | 100,000 | $28.96 | $2896K |
| McNeill Jonathan | Chief Business Officer | 2024-03-01 | SELL | 28,528 | $28.46 | $811.9K |
| Scalzo Richard William | SVP, Head of Finance & Admin. | 2024-03-01 | SELL | 12,740 | $28.05 | $357.4K |
| Atlas Venture Opportunity Fund I, L.P. | 10% Owner | 2024-03-01 | SELL | 46,534 | $30.05 | $1398.3K |
| Farwell Wildon | Chief Medical Officer | 2024-02-28 | SELL | 407 | $25 | $10.2K |
| Rhodes Jason P | Director | 2024-02-28 | SELL | 807,838 | $24.3 | $19630.5K |
| Atlas Venture Fund XI, L.P. | 10% Owner | 2024-02-28 | SELL | 807,838 | $24.3 | $19630.5K |
| Rhodes Jason P | Director | 2024-02-23 | SELL | 500,789 | $22.64 | $11337.9K |
| Atlas Venture Fund XI, L.P. | 10% Owner | 2024-02-23 | SELL | 500,789 | $22.64 | $11337.9K |
| Rhodes Jason P | Director | 2024-02-20 | SELL | 510,152 | $23.26 | $11866.1K |
| Atlas Venture Fund XI, L.P. | 10% Owner | 2024-02-20 | SELL | 510,152 | $23.26 | $11866.1K |
| Farwell Wildon | Chief Medical Officer | 2024-02-12 | SELL | 5,493 | $25.07 | $137.7K |
| Farwell Wildon | Chief Medical Officer | 2024-01-26 | SELL | 100 | $25 | $2.5K |
| McNeill Jonathan | Chief Business Officer | 2024-01-26 | SELL | 20,000 | $24.53 | $490.6K |
| Scalzo Richard William | SVP, Head of Finance & Admin. | 2024-01-26 | SELL | 13,000 | $24.34 | $316.4K |
| Kersten Dirk | Director, 10% Owner | 2024-01-09 | BUY | 1,714,285 | $17.5 | $30000K |
| Brumm Joshua T | CEO & President | 2024-01-04 | SELL | 269,719 | $18.66 | $5033K |
| Beskrovnaya Oxana | Chief Scientific Officer | 2024-01-04 | SELL | 87,779 | $18.57 | $1630.1K |
| McNeill Jonathan | Chief Business Officer | 2024-01-04 | SELL | 31,900 | $16.59 | $529.2K |
| Scalzo Richard William | SVP, Head of Finance & Admin. | 2024-01-03 | SELL | 13,000 | $18.81 | $244.5K |
| Scalzo Richard William | See Remarks | 2023-12-14 | SELL | 2,376 | $12.02 | $28.6K |
| Farwell Wildon | Chief Medical Officer | 2023-12-12 | SELL | 2,666 | $10.66 | $28.4K |
| Brumm Joshua T | See Remarks | 2023-12-11 | SELL | 7,585 | $10.72 | $81.3K |
| Beskrovnaya Oxana | Chief Scientific Officer | 2023-12-11 | SELL | 1,467 | $10.72 | $15.7K |
| Scalzo Richard William | See Remarks | 2023-12-11 | SELL | 1,380 | $10.72 | $14.8K |
| McNeill Jonathan | Chief Business Officer | 2023-12-11 | SELL | 1,245 | $10.72 | $13.3K |
| HIGH SUSANNA GATTI | COO | 2023-12-11 | SELL | 1,616 | $10.72 | $17.3K |
| Scalzo Richard William | See Remarks | 2023-12-06 | SELL | 2,553 | $12.01 | $30.7K |
| HIGH SUSANNA GATTI | COO | 2023-11-02 | SELL | 9,939 | $7.4 | $73.5K |
| Scalzo Richard William | See Remarks | 2023-09-18 | SELL | 1,290 | $9.41 | $12.1K |
| McNeill Jonathan | Chief Business Officer | 2023-09-18 | SELL | 1,261 | $9.41 | $11.9K |
| HIGH SUSANNA GATTI | COO | 2023-09-18 | SELL | 2,672 | $9.41 | $25.1K |
| Brumm Joshua T | See Remarks | 2023-09-18 | SELL | 12,032 | $9.41 | $113.2K |
| Beskrovnaya Oxana | Chief Scientific Officer | 2023-09-18 | SELL | 1,436 | $9.41 | $13.5K |
| Farwell Wildon | Chief Medical Officer | 2023-09-12 | SELL | 1,707 | $10.41 | $17.8K |
| Scalzo Richard William | See Remarks | 2023-09-12 | SELL | 1,397 | $10.41 | $14.5K |
| McNeill Jonathan | Chief Business Officer | 2023-09-12 | SELL | 1,266 | $10.41 | $13.2K |
| HIGH SUSANNA GATTI | COO | 2023-09-12 | SELL | 1,635 | $10.41 | $17K |
| Brumm Joshua T | See Remarks | 2023-09-12 | SELL | 7,672 | $10.41 | $79.9K |
| Beskrovnaya Oxana | Chief Scientific Officer | 2023-09-12 | SELL | 1,484 | $10.41 | $15.4K |
| Scalzo Richard William | See Remarks | 2023-06-15 | SELL | 51,390 | $12.71 | $653.2K |
| McNeill Jonathan | See Remarks | 2023-06-13 | SELL | 2,259 | $12.68 | $28.6K |
| HIGH SUSANNA GATTI | COO | 2023-06-13 | SELL | 1,625 | $12.43 | $20.2K |
| Farwell Wildon | Chief Medical Officer | 2023-06-13 | SELL | 1,698 | $12.43 | $21.1K |
| Beskrovnaya Oxana | Chief Scientific Officer | 2023-06-13 | SELL | 1,475 | $12.43 | $18.3K |
| Brumm Joshua T | See Remarks | 2023-06-12 | SELL | 325,330 | $12.9 | $4196.8K |
| Scalzo Richard William | See Remarks | 2023-03-14 | SELL | 1,311 | $13.33 | $17.5K |
| McNeill Jonathan | See Remarks | 2023-03-14 | SELL | 2,209 | $13.18 | $29.1K |
| HIGH SUSANNA GATTI | COO | 2023-03-14 | SELL | 1,559 | $13.33 | $20.8K |
| Farwell Wildon | Chief Medical Officer | 2023-03-14 | SELL | 7,441 | $13.33 | $99.2K |
| Brumm Joshua T | See Remarks | 2023-03-14 | SELL | 7,318 | $13.33 | $97.5K |
| Beskrovnaya Oxana | Chief Scientific Officer | 2023-03-14 | SELL | 1,416 | $13.33 | $18.9K |
| McNeill Jonathan | See Remarks | 2023-01-18 | SELL | 10,000 | $14.03 | $140.3K |
| McNeill Jonathan | See Remarks | 2023-01-09 | SELL | 30,150 | $11.57 | $348.8K |
| Rhodes Jason P | Director | 2022-12-12 | BUY | 934,581 | $10.7 | $10000K |
| Atlas Venture Fund XI, L.P. | 10% Owner | 2022-12-12 | BUY | 934,581 | $10.7 | $10000K |
| Scalzo Richard William | See Remarks | 2022-12-12 | SELL | 312 | $10.87 | $3.4K |
| McNeill Jonathan | See Remarks | 2022-12-12 | SELL | 472 | $10.87 | $5.1K |
| HIGH SUSANNA GATTI | COO | 2022-12-12 | SELL | 751 | $10.87 | $8.2K |
| Farwell Wildon | Chief Medical Officer | 2022-12-12 | SELL | 628 | $10.87 | $6.8K |
| Brumm Joshua T | See Remarks | 2022-12-12 | SELL | 3,322 | $10.87 | $36.1K |
| Beskrovnaya Oxana | Chief Scientific Officer | 2022-12-12 | SELL | 680 | $10.87 | $7.4K |
| Brumm Joshua T | See Remarks | 2022-10-10 | SELL | 210,000 | $12.52 | $2629.2K |
| Farwell Wildon | Chief Medical Officer | 2022-03-02 | SELL | 5,617 | $8.56 | $48.1K |
| HIGH SUSANNA GATTI | COO | 2021-09-23 | SELL | 2,451 | $17.22 | $42.2K |
| Scalzo Richard William | See Remarks | 2021-09-21 | SELL | 859 | $15.9 | $13.7K |
| McNeill Jonathan | See Remarks | 2021-09-21 | SELL | 1,274 | $15.9 | $20.3K |
| Brumm Joshua T | See Remarks | 2021-09-21 | SELL | 8,009 | $15.9 | $127.3K |
| Beskrovnaya Oxana | Chief Scientific Officer | 2021-09-21 | SELL | 1,444 | $15.9 | $23K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked